摘要
目的:观察诺迪康胶囊治疗糖尿病足的临床疗效。方法:采用双盲随机对照观察,将64例2型糖尿病患者分为两组,诺迪康胶囊治疗组34例,活血通脉胶囊治疗组30例,诺迪康胶囊治疗组服用诺迪康胶囊每次4粒,每日3次;活血通脉组服用活血通脉胶囊每次4粒,每日3次。结果:诺迪康组在缓解下肢缺血症状、间歇性跛行的症状以及提高血液流变学改善率方面均优于活血通脉组(P<0.05)。结论:诺迪康胶囊改善下肢血管疗效确切,安全可靠,可作为糖尿病足治疗的首选药物之一。
Objective：To observe the clinical effect on treating diabetic foot by Nuodikang capsules.Methods：Double blind and random comparison,64 cases of diabetic were divided into two groups.34 cases for Nuodikang capsules, 30 cases for Huoxuetongmai sules.Results：The group of Nuodikang could relief the lower limb ischemia, intermittent claudication better and had a better improvement rate of hemorheology than that of group Huoxuetongmai （P0.05）.Conclusion：Nuodikang capsules can improve the lower extremity＇s blood vessels correctly and safely, it is a better choice drug to treat diabetic foot.
出处
《中国当代医药》
2010年第28期49-50,共2页
China Modern Medicine
